Key facts
- This page summarizes Christopher Paul Simms's Form 3 filing for IVERIC bio, Inc..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 Aug 2021, 19:50.
Christopher Paul Simms - 02 Aug 2021 Form 3 Insider Report for IVERIC bio, Inc.
- Reporting relationship
- Senior Vice President, CCO
- Issuer ticker
- N/A
- Reported as of
- 02 Aug 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 04 Aug 2021, 19:50:13 UTC
- Next SEC filing
- 22 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Todd Anderman as attorney-in-fact for Christopher Simms
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Christopher Paul Simms filed Form 3 for IVERIC bio, Inc. on 04 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ISEE
holding
Common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,000
- Date
- 02 Aug 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit 24 - Power of Attorney